US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

37.18

0.0000

Volume:17

Turnover:635.82

Market Cap:17.47M

PE:- -

High:37.18

Open:37.18

Low:37.18

Close:37.18

52wk High:37.90

52wk Low:28.87

Shares:469.95K

Float Shares:469.95K

Volume Ratio:0.42

T/O Rate:0.00%

Dividend:0.41

Dividend Rate:1.10%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Johnson & Johnson Names New Vice President for Litigation

Stocks Ex-Dividend August 25

AbbVie Expands Aesthetics Pipeline With New Phase 2 Forehead Lines Study

Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial

AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch

Eli Lilly’s Dulaglutide Study Sheds Light on Fasting Risks and Diabetes Care

AbbVie’s Emraclidine Schizophrenia Study Ends Early: What Investors Need to Know Now

Three Scientists Beat J&J's Defamation Suit over Talc Research

Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy.

Johnson & Johnson Says Multiple Myeloma Treatment Approved by European Commission

MT Newswires Live

Guizhou Unveils 13 Typical Cases of Consumer Rights Violations in Market Regulation Crackdown

Press Release: 3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth

Apichope's Subsidiary Gains Regulatory Nod for Novel Drug Trial Application

When This Sector Rallies, Tech Takes a Backseat

Press Release: Sunshine Guojian Releases 2026 Interim Report:

Perrigo Co. PLC Stock Outperforms Competitors Despite Losses on the Day

Does J&J’s MONARCH QUEST 3 Approval and MedTech Momentum Change The Bull Case For Johnson & Johnson (JNJ)?

Simply Wall St.

AbbVie Targets Next-Gen BOTOX Combo With New Glabellar Lines Study

Eli Lilly Advances Early-Stage Eloralintide Trial: What Investors Should Watch

Eli Lilly’s Lebrikizumab Trial Completion Signals New Growth Path in Atopic Dermatitis

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/MEDX/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":37.1775,"timestamp":1788442205264,"preClose":37.1775,"halted":0,"volume":17,"delay":0,"changeRate":0,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"09-03 09:36:58 EDT","open":37.1775,"high":37.1775,"low":37.1775,"amount":635.8192779999999,"amplitude":0,"askPrice":37.19,"askSize":700,"bidPrice":36.94,"bidSize":700,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788465600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":37.1775,"sharesOutstanding":569946,"nav":36.75,"aum":17270515.5,"dividendRate":0.010972,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":37.105,"preClose":37.1775,"latestTime":"16:10 EDT","volume":6,"amount":222.85,"timestamp":1788379804403,"change":-0.0725,"changeRate":-0.00195,"amplitude":0},"volumeRatio":0.422417},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.422417,"shares":469946,"dividePrice":0.4079,"high":37.1775,"amplitude":0,"preClose":37.1775,"low":37.1775,"week52Low":28.8652,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":37.1775,"eps":0,"divideRate":0.010972,"volume":17,"delay":0,"ttmEps":0,"open":37.1775,"prevYearClose":33.2024,"prevWeekClose":36.5564,"prevMonthClose":36.417,"prevQuarterClose":36.7138,"fiveDayClose":36.8878,"twentyDayClose":35.3272,"sixtyDayClose":34.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661297383","title":"Johnson & Johnson Names New Vice President for Litigation","url":"https://stock-news.laohu8.com/highlight/detail?id=2661297383","media":"Reuters","labels":["executive","policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661297383?lang=en_us&edition=fundamental","pubTime":"2026-08-22 03:52","pubTimestamp":1787341979,"startTime":"0","endTime":"0","summary":"Johnson & Johnson names new vice president for litigationNEW YORK, Aug 21 (Reuters)-Johnson & Johnson is getting a new vice president in charge of litigation about a month after announcing an agreemen","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL1N44I0OS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3PB1722.GBP","IE0002270589.USD","BK4581","LU1989771016.USD","PJP","JNJ","XLV","GDOC","LU2896262040.SGD","IXJ","LU2213496289.HKD","IE00B42XCP33.USD","LU0070217475.USD","IE00BFXG1179.USD","LU0058720904.USD","BK4550","LU2089984988.USD","SGXZ80539844.SGD","LU0234570918.USD","IHE","IE00B19Z3581.USD","LU1228905037.USD","BK4568","JDOC","SG9999001440.SGD","RXL","LU2133065610.SGD","LU1261432733.SGD","LU2430703178.SGD","LU0792757196.USD","LU0289739699.SGD","TRUH","IYH","IE00BJT1NW94.SGD","LU1430594728.SGD","VHT","LU0882574055.USD","FTXH","LU0912757837.SGD","LU0889566641.SGD","LU0203347892.USD","MEDX","IE00BN8TJ469.HKD","LU0640476718.USD","IE00BJJMRZ35.SGD","FHLC","IE00BZ1G4Q59.USD","LU1057294990.SGD","IE00B19Z3B42.SGD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661927252","title":"Stocks Ex-Dividend August 25","url":"https://stock-news.laohu8.com/highlight/detail?id=2661927252","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661927252?lang=en_us&edition=fundamental","pubTime":"2026-08-22 03:40","pubTimestamp":1787341200,"startTime":"0","endTime":"0","summary":"BitMine Immer 9.5% Pfd. A     BMNP         5.3     0.1583","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","LU0787776722.HKD","LU0234570918.USD","FTXH","LU0792757196.USD","LU2430703251.USD","IYH","IHE","BMED","XLV","IXJ","IE00BBT3K403.USD","LU1032466523.USD","LU2592432038.USD","LU2403377893.USD","TRUH","BK4550","LU2896262040.SGD","LU1061106388.HKD","LU1989771016.USD","LU1121112475.USD","IE00BLSP4239.USD","RXL","LU0820562030.AUD","LU0058720904.USD","SG9999001440.SGD","LU0882574055.USD","JNJ","LU2347655156.SGD","LU1228905540.USD","IE00BKVL7J92.USD","LU0426417589.USD","BK4504","LU1066051498.USD","IE0034235303.USD","BXE.SI","LU0795875086.SGD","MEDX","IE00BJT1NW94.SGD","FHLC","LU0994945656.USD","LU1629891620.HKD","GDOC","VHT","LU0889566641.SGD","JDOC","LU1043141396.HKD","BK4007","LU0820561818.USD","LU1778281490.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661291072","title":"AbbVie Expands Aesthetics Pipeline With New Phase 2 Forehead Lines Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2661291072","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661291072?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:33","pubTimestamp":1787330012,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie is running a Phase 2 study called “A Phase 2 Open-Label Study to Evaluat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvie-expands-aesthetics-pipeline-with-new-phase-2-forehead-lines-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvie-expands-aesthetics-pipeline-with-new-phase-2-forehead-lines-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0158827948.USD","LU2125909593.SGD","FTXH","IE0004445239.USD","IE000SO60NU8.SGD","IE00B19Z3B42.SGD","SG9999003800.SGD","IE00B19Z3581.USD","IE00B42XCP33.USD","AGNG","ABBV","LU0198837287.USD","LU2347655073.USD","FHLC","LU0545039389.USD","LU0661504455.SGD","PJP","RXL","IXJ","LU2237443622.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","IE0009355771.USD","LU2023251221.USD","IE00BLSP4239.USD","LU2089284900.SGD","SG9999011175.SGD","LU0859254822.USD","LU0122379950.USD","XLV","LU1291159041.SGD","LU1585245621.USD","SG9999015952.SGD","TRUH","LU0170899867.USD","LU0965509010.AUD","LU0708994859.HKD","IE0002270589.USD","VHT","IE00BSNM7G36.USD","GLAM","LU1934455194.USD","IYH","LU0965509101.SGD","PPH","LU0128525929.USD","MEDX","JDOC","LU0965509283.SGD","LU0943347566.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661729483","title":"Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661729483","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661729483?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:33","pubTimestamp":1787329988,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Eli Lilly and Co. (LLY) is running a Phase 3b study called ACHIEV...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eli-lilly-targets-ramadan-diabetes-market-with-new-orforglipron-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eli-lilly-targets-ramadan-diabetes-market-with-new-orforglipron-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2265009873.SGD","LU0266013472.USD","LU1548497426.USD","LU1064131342.USD","ILDR","LU0820561909.HKD","SG9999015978.USD","LU2236285917.USD","MEDX","CURE","LU0133085943.USD","VHT","IE0002141913.USD","PJP","LU0345770993.USD","WDNA","LU1629891620.HKD","IHE","LU2360106947.USD","LU2462591350.SGD","LU0471298777.SGD","IE00B1BXHZ80.USD","LU1720051108.HKD","IE00BJLML261.HKD","LU2746668974.SGD","IE0001KFT4U8.USD","THNR","BK4516","IE00BN29S564.USD","LU0234572021.USD","LU1023059063.AUD","SG9999001176.USD","LU0106261372.USD","LU0432979614.USD","LU0683600562.USD","ELIS","JDOC","LU1988902786.USD","LU2237443622.USD","LU2471134796.USD","LU2756315318.SGD","LU0203201768.USD","FHLC","LU1267930730.SGD","LU1868836914.USD","LU2361045086.USD","IE00BJJMRX11.SGD","BK4581","SG9999015945.SGD","AGNG","LU1057294990.SGD","LU2237443549.SGD","LU0320765992.SGD","SG9999014898.SGD","IE0004445015.USD","SGXZ57979304.SGD","LU0096364046.USD","LU0882574055.USD","LU2211815571.USD","IE0004445239.USD","LU2471134952.CNY","LU0672654240.SGD","LU2491049909.HKD","TMED","ELIL","LLY","LU2023250330.USD","LU0882574139.USD","LU2168564149.EUR","IXJ","LU1868836591.USD","TRUH","SG9999017495.SGD","MEDI","LU2237443382.USD","SG9999015952.SGD","LU1712237335.SGD","LU0320765059.SGD","LU1069344957.HKD","SGXZ51526630.SGD","RXL","LU0943347566.SGD","IE00BK4W5L77.USD","LU0225283273.USD","LU1093756168.USD","LU2471134879.HKD","LU2461242641.AUD","MHIP","LU0820562030.AUD","LU0316494557.USD","BK4588","LU0353189763.USD","LU2089984988.USD","LU2023251221.USD","LU2552382132.HKD","LU0203202063.USD","LU0158827781.USD","LU0345770308.USD","LU2361044949.HKD","LU0174119429.USD","LU0787776722.HKD","BK4599","LU0256863811.USD","LU1280957306.USD","LU0006306889.USD","LU0820561818.USD","LU1366192091.USD","LU1127390331.HKD","LU2106854487.HKD","LU0061475181.USD","LU0353189680.USD","LU1145028129.USD","LU0109394709.USD","IE00BJT1NW94.SGD","PPH","LU0823416689.USD","LU1093756325.SGD","IE0009355771.USD","LU2491050071.SGD","SG9999014906.USD","LU2361044865.SGD","IE00BFSS8Q28.SGD","LLII","LU2237443978.SGD","LU2552382215.SGD","LU0109391861.USD","LU0158827948.USD","LU2750360641.GBP","LU2491050154.USD","LU2324357040.USD","LU0708995401.HKD","LU1035775433.USD","LU2168564065.EUR","SG9999014880.SGD","IE00BK4W5M84.HKD","SG9999013999.USD","GDOC","LU0198837287.USD","LU1551013342.USD","LU1061106388.HKD","LU2063271972.USD","IE0005OL40V9.USD","LU0640476718.USD","LU0079474960.USD","IE00BFTCPJ56.SGD","LU1804176565.USD","FTXH","IE00B2B36J28.USD","LU0354030511.USD","LU0210536198.USD","SGXZ31699556.SGD","LU0471298694.HKD","LU0354030438.USD","LU1323610961.USD","LU1720051017.SGD","LU2112291526.USD","LU2168564222.USD","IE00B4R5TH58.HKD","IE00B1XK9C88.USD","IE00B7KXQ091.USD","LU2746668461.USD","LU1979441026.SGD","LU0786609619.USD","LU2456880835.USD","LU1551013425.SGD","LU2237438978.USD","IE00BWXC8680.SGD","LU0823434740.USD","LU0889565916.HKD","IE00B775H168.HKD","LU2111349929.HKD","LU2417539215.USD","SG9999014914.USD","LLYZ","LU0114720955.EUR","SG9999001176.SGD","LU2602419157.SGD","LU1868836757.USD","LU0456855351.SGD","LU2896262040.SGD","LU2237443465.HKD","LU0323591593.USD","XLV","LU1868837300.USD","LU1989771016.USD","OZEM","LU2168563687.JPY","LU1917777945.USD","SG9999015986.USD","BK4534","LU0417517546.SGD","LU1974910355.USD","LU2023250504.SGD","IE00BKPKM429.USD","LU2468319806.SGD","LU1868837136.USD","LU2087625088.SGD","LU2750360997.AUD","LU2756315664.SGD","LU0256863902.USD","LU0823434583.USD","LU2168564495.EUR","IE00BJJMRZ35.SGD","LU0385154629.USD","LU1291159041.SGD","SGXZ81514606.USD","BK4007","IE00B4JS1V06.HKD","LU1691799644.USD","SG9999018865.SGD","LU0122379950.USD","LU2237443895.HKD","LU2271345857.HKD","LU1983299246.USD","GB00BDT5M118.USD","LU2028103732.USD","LU0466842654.USD","LU2089283258.USD","LU2357305700.SGD","LU0238689110.USD","LU1623119135.USD","LU2264538146.SGD","LU2462157665.USD","LU0689472784.USD","LU0058720904.USD","LU2552382058.USD","SG9999018857.SGD","LU1814569148.SGD","SGXZ99366536.SGD","IE00BKDWB100.SGD","LU1232071149.USD","LU2108987350.USD","IE00BFSS7M15.SGD","LU2089284900.SGD","BK4585","LLYX","LU0094547139.USD","LU0097036916.USD","IYH","IE00BJJMRY28.SGD","CANC","LU2213496289.HKD","BK4533","LU2471134523.USD","LU0289739699.SGD","LU0964807845.USD","HRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661294839","title":"AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2661294839","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661294839?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:31","pubTimestamp":1787329917,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. The Phase 3 study “A Phase 3 Randomized, Placebo-controlled, Double-blind Study...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-pediatric-alopecia-with-new-phase-3-trial-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-pediatric-alopecia-with-new-phase-3-trial-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1989772923.USD","LU2237443549.SGD","ABBV","GLAM","LU2089284900.SGD","LU2237443978.SGD","LU1989771016.USD","BK4139","LU0823416689.USD","LU0861579265.USD","LU0949170772.SGD","PJP","XLV","IXJ","IE00B42XCP33.USD","AGNG","LU1496350171.SGD","LU0795875169.SGD","IE00BGHQF631.EUR","LU2433249047.HKD","IE00BBT3K403.USD","PPH","JDOC","LU0689626769.HKD","LU0456855351.SGD","RXL","LU0689472784.USD","LU0122379950.USD","ISBC","TRUH","LU0417517546.SGD","LU1244550577.SGD","IYH","LU2125909593.SGD","SG9999015945.SGD","LU2237443895.HKD","LU0820561818.USD","LU0868494617.USD","LU2129689514.USD","VHT","FTXH","LU0912757837.SGD","LU1989772840.SGD","MEDX","LU1934455277.USD","IE00BN8TJ469.HKD","FHLC","LU0545039389.USD","IE00B19Z3B42.SGD","LU0395794307.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661948602","title":"Eli Lilly’s Dulaglutide Study Sheds Light on Fasting Risks and Diabetes Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2661948602","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661948602?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:31","pubTimestamp":1787329867,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. The study, titled “A Study to Evaluate the Effect of Fasting Dura...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eli-lillys-dulaglutide-study-sheds-light-on-fasting-risks-and-diabetes-care?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eli-lillys-dulaglutide-study-sheds-light-on-fasting-risks-and-diabetes-care?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0820561818.USD","IE00B775H168.HKD","LU2417539215.USD","SG9999001176.USD","LU0234572021.USD","SGXZ81514606.USD","LU1979441026.SGD","LU1974910355.USD","LU1064131342.USD","CANC","LU1551013425.SGD","OZEM","LU1291159041.SGD","IXJ","LU0882574055.USD","LU1629891620.HKD","SGXZ51526630.SGD","LU2213496289.HKD","LU0385154629.USD","LU0114720955.EUR","LU2087625088.SGD","LU2456880835.USD","LU1868837136.USD","GDOC","LU0210536198.USD","BK4516","LU1023059063.AUD","LU1366192091.USD","LU2237443895.HKD","LU1720051017.SGD","LU2211815571.USD","BK4533","LU2746668461.USD","LU2471134879.HKD","LU0109391861.USD","LU0203201768.USD","IE00B7KXQ091.USD","SG9999018865.SGD","LU2471134796.USD","LU0823434583.USD","LU1868836914.USD","TRUH","SG9999015945.SGD","LU1868837300.USD","MEDX","LU2023250504.SGD","IE00BKDWB100.SGD","LU0882574139.USD","LU2361044949.HKD","LU2471134523.USD","MHIP","LU0266013472.USD","IE00BK4W5L77.USD","LU0289739699.SGD","LU0417517546.SGD","LU2602419157.SGD","IE00B4R5TH58.HKD","SGXZ31699556.SGD","SGXZ57979304.SGD","LU0158827781.USD","LU0097036916.USD","LU1057294990.SGD","LU0964807845.USD","BK4534","LU0353189680.USD","LU2271345857.HKD","LLY","LU0079474960.USD","IHE","LU0158827948.USD","LU1061106388.HKD","LU1267930730.SGD","LU1720051108.HKD","LU0198837287.USD","CURE","LU2168564222.USD","LU1983299246.USD","LU0096364046.USD","LU2089283258.USD","LU2089284900.SGD","LU2265009873.SGD","LU2756315664.SGD","LU0672654240.SGD","MEDI","LU1232071149.USD","LU0432979614.USD","LU2750360641.GBP","LU1551013342.USD","LU0786609619.USD","LU0320765059.SGD","IE0001KFT4U8.USD","IE00B1XK9C88.USD","BK4581","LU2111349929.HKD","IE00BJJMRZ35.SGD","LU1145028129.USD","LU2168564149.EUR","LU2236285917.USD","LU2237443465.HKD","LU2237443549.SGD","FTXH","LU2462591350.SGD","LU2552382058.USD","LU0058720904.USD","LU0943347566.SGD","IE00BN29S564.USD","LU0354030511.USD","BK4588","SG9999015978.USD","LU0820561909.HKD","LU0471298777.SGD","LU2462157665.USD","IE0004445239.USD","LU0820562030.AUD","LU2896262040.SGD","LU2108987350.USD","LU1623119135.USD","ELIL","LU0323591593.USD","LU2360106947.USD","LU2471134952.CNY","THNR","VHT","LU2112291526.USD","LU2237443622.USD","IE00BJJMRX11.SGD","LU0094547139.USD","LU2237443978.SGD","IE00B4JS1V06.HKD","LU0689472784.USD","LU0061475181.USD","LU0640476718.USD","LU2324357040.USD","SG9999017495.SGD","SG9999018857.SGD","XLV","LU1093756325.SGD","LU2756315318.SGD","SG9999014906.USD","LU0006306889.USD","LU2106854487.HKD","TMED","BK4599","LU2168563687.JPY","IE00BFTCPJ56.SGD","LU0354030438.USD","LU1323610961.USD","IE00BFSS8Q28.SGD","JDOC","LU1280957306.USD","LU1989771016.USD","LU0889565916.HKD","LU0466842654.USD","LU0109394709.USD","LU2468319806.SGD","IE0002141913.USD","LU0345770308.USD","LU1804176565.USD","SGXZ99366536.SGD","LU0683600562.USD","LU1712237335.SGD","LU2063271972.USD","FHLC","LU1035775433.USD","IE00BJLML261.HKD","LU2237443382.USD","WDNA","BK4007","LU2361045086.USD","LU0238689110.USD","LU2168564065.EUR","LLYX","LU2750360997.AUD","LU1868836591.USD","IE0005OL40V9.USD","LU2491049909.HKD","LU1814569148.SGD","LU2168564495.EUR","LU0174119429.USD","LU2023251221.USD","ILDR","LU2028103732.USD","LU1691799644.USD","LU2023250330.USD","LU2089984988.USD","LU2491050071.SGD","PPH","IE00B1BXHZ80.USD","IYH","LU0345770993.USD","LU0471298694.HKD","SG9999014914.USD","LU2237438978.USD","SG9999001176.SGD","ELIS","LU0256863902.USD","LU0353189763.USD","LU1868836757.USD","IE00BJJMRY28.SGD","LU1093756168.USD","LU0823434740.USD","LU2264538146.SGD","LU2361044865.SGD","LU0320765992.SGD","IE00BFSS7M15.SGD","LU1069344957.HKD","IE0009355771.USD","SG9999014898.SGD","LLII","LU2746668974.SGD","IE00B2B36J28.USD","IE00BK4W5M84.HKD","LU0316494557.USD","LU0708995401.HKD","SG9999015986.USD","LU1548497426.USD","IE0004445015.USD","PJP","LU0203202063.USD","IE00BJT1NW94.SGD","LU0133085943.USD","LU2552382215.SGD","HRTS","LU0256863811.USD","LU2461242641.AUD","SG9999014880.SGD","LU0456855351.SGD","LU0787776722.HKD","IE00BKPKM429.USD","AGNG","LU0225283273.USD","LU2357305700.SGD","LU0106261372.USD","SG9999015952.SGD","BK4585","LU2491050154.USD","LU1917777945.USD","IE00BWXC8680.SGD","LLYZ","LU0823416689.USD","LU1988902786.USD","RXL","LU0122379950.USD","GB00BDT5M118.USD","LU1127390331.HKD","SG9999013999.USD","LU2552382132.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661294820","title":"AbbVie’s Emraclidine Schizophrenia Study Ends Early: What Investors Need to Know Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2661294820","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661294820?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:30","pubTimestamp":1787329825,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie’s long-term Phase 2 trial NCT05443724, titled “A 52-week, Phase 2, Open-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-emraclidine-schizophrenia-study-ends-early-what-investors-need-to-know-now?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-emraclidine-schizophrenia-study-ends-early-what-investors-need-to-know-now?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0795875086.SGD","LU0943347566.SGD","IE00B19Z3B42.SGD","FHLC","LU0689626769.HKD","LU2023251221.USD","BK4550","IE00B4R5TH58.HKD","LU1244550494.USD","LU0029864427.USD","SG9999003800.SGD","BK4588","LU1989772840.SGD","PJP","LU1267930490.SGD","BK4534","IE00BJT1NW94.SGD","ABBV","LU2237443895.HKD","FTXH","IE000F7OJYX1.SGD","LU0310799852.SGD","LU1551013342.USD","LU1929549753.HKD","IE00BN8TJ469.HKD","ISBC","IE0004445239.USD","JDOC","PPH","LU0432979614.USD","LU1934455863.HKD","RXL","LU1093756168.USD","IYH","PSIL","GLAM","AGNG","SG9999001440.SGD","LU0158827948.USD","LU1003077747.HKD","LU0234570918.USD","TRUH","XLV","VHT","LU0256863811.USD","LU0708994859.HKD","BBC","IXJ","MEDX","LU0861579265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661291757","title":"Three Scientists Beat J&J's Defamation Suit over Talc Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2661291757","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661291757?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:27","pubTimestamp":1787329644,"startTime":"0","endTime":"0","summary":"Three scientists beat J&J's defamation suit over talc researchNEW YORK, Aug 21 (Reuters)-A U.S. judge in Virginia has ruled that three researchers did not defame Johnson & Johnson by publishing resear","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL1N44H0WW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770993.USD","IE0034235303.USD","LU1145028129.USD","LU1496350502.SGD","LU2430703178.SGD","LU0320765646.SGD","LU0466842654.USD","LU1221951129.SGD","IE00B19Z3B42.SGD","BK4559","JDOC","LU1935042991.SGD","LU1894683264.USD","IE00BLSP4452.SGD","IE000WAW04H5.SGD","LU0345769128.USD","IYH","IE0002141913.USD","LU1023059063.AUD","PJP","RXL","IXJ","VHT","LU0210536198.USD","LU1196500208.SGD","IE000M9KFDE8.USD","LU2750360997.AUD","SG9999002224.SGD","LU2430703095.HKD","LU0289739699.SGD","BMED","LU1551013425.SGD","FHLC","BK4581","GDOC","LU1057294990.SGD","BK4550","LU1914381329.SGD","IHE","IE000MB6IJN5.SGD","TRUH","XLV","IE00B42XCP33.USD","JNJ","LU0985320562.USD","LU1066051498.USD","LU0345769631.USD","LU2417539215.USD","FTXH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260294","title":"Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy.","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260294","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260294?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:08","pubTimestamp":1787314080,"startTime":"0","endTime":"0","summary":"Biopharmaceutical stocks have emerged winners. Only some will continue to gain.The iShares Biotechnology Exchange-Traded Fund, home to some large pharma companies and many smaller biotechs, have risen","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130517989.USD","LU0471298694.HKD","LU0321505439.SGD","IE0002270589.USD","HRTS","LU0289739699.SGD","LGHT","ILDR","IHE","RXL","LU1232071149.USD","LU2552382215.SGD","LU2087625088.SGD","LU0868494708.USD","LU2456880835.USD","LU2237443382.USD","MRNA","LU1061106388.HKD","IE00B775H168.HKD","LU2596442595.SGD","LU0238689110.USD","LU1548497426.USD","LU0354030511.USD","LU0964807845.USD","LU2237443465.HKD","GNOM","MRNY","LU0079474960.USD","LU0109394709.USD","LU2108987350.USD","SG9999014559.SGD","LU1066051225.USD","LU2111349929.HKD","LU1291159041.SGD","LU2602419157.SGD","IE00BN8TJ469.HKD","LU2360106947.USD","LU1323610961.USD","LU0353189680.USD","LU2168564495.EUR","ELIS","LU0097036916.USD","LU0211331839.USD","LU1923622614.USD","IE00BWXC8680.SGD","LU0096364046.USD","LLYX","LU0203345920.USD","IE00BJLML261.HKD","SG9999014567.USD","LU0466842654.USD","LU1699723380.USD","SGXZ57979304.SGD","LU1066051811.HKD","LU2106854487.HKD","LU2896262040.SGD","LU2361044949.HKD","LU0965509283.SGD","LU0943347566.SGD","LU1934455277.USD","IE00BFSS8Q28.SGD","LU0234572021.USD","LU2125909247.SGD","LU2168563687.JPY","LU2112291526.USD","LU2089283258.USD","SG9999015945.SGD","LU0985481810.HKD","LU1551013342.USD","LU0203202063.USD","LU0354030438.USD","LU0098860793.USD","SG9999015986.USD","LU0130102774.USD","LU2168564222.USD","LU2264538146.SGD","LU1162221912.USD","LU1934455194.USD","LU0316494557.USD","LU2125154778.USD","BK4007","LU1974910355.USD","LU1894683264.USD","LU2552382132.HKD","IE00B3T34201.USD","LU0708995401.HKD","LU1035775433.USD","WDNA","PPH","LU0323591593.USD","LU0823434583.USD","LU2168564065.EUR","LU1093756168.USD","IE00BFSS7M15.SGD","XLV","LU0265550946.USD","LU1551013425.SGD","LU1720051108.HKD","SG9999014542.SGD","BK4568","LU1035773651.USD","LU0320765646.SGD","LU0306806265.USD","IE00BJT1NW94.SGD","LU2491050071.SGD","LU2357627491.SGD","LU2237443549.SGD","LU1883839398.USD","LU1585245621.USD","IE00B4R5TH58.HKD","LU0124676726.USD","BK4534","LU2237443622.USD","LU0353189763.USD","LU0648001328.SGD","LU0882574139.USD","LU1366192091.USD","PAWZ","SG9999013999.USD","LU1868836914.USD","LU2125909593.SGD","FHLC","LU2417539215.USD","LU0889565916.HKD","VHT","LU2491049909.HKD","SG9999003800.SGD","LU0070302665.USD","GDOC","LU2471134952.CNY","LU0689472784.USD","LU0823434740.USD","LU2357305700.SGD","SG9999017495.SGD","LU2023250330.USD","LU0859254822.USD","LLYZ","BK4588","LU2125154935.USD","BK4559","IE00BJJMRX11.SGD","LU2756315318.SGD","IE0001KFT4U8.USD","LU0820561909.HKD","LU2471134796.USD","LU0471298777.SGD","IE00B1XK9C88.USD","LU0256863811.USD","IE0005OL40V9.USD","IXJ","BK4532","LU0061475181.USD","LU2746668461.USD","LU1983299246.USD","LU1629891620.HKD","SG9999018865.SGD","LU2361045086.USD","LU0094547139.USD","IE00BBT3K403.USD","IYH","LU0477156953.USD","IDNA","LU0868494617.USD","SG9999014914.USD","LU0109391861.USD","LU0133085943.USD","LU1127390331.HKD","SG9999014575.USD","LU2168564149.EUR","LU2265009873.SGD","LU2063271972.USD","LU0058720904.USD","LU1037948897.HKD","LU2361044865.SGD","MEDX","LU0266013472.USD","LU0965509101.SGD","LU0174119429.USD","SG9999002224.SGD","SG9999015341.SGD","LU1201861249.SGD","LU1804176565.USD","LU0965509010.AUD","LU1929549753.HKD","JDOC","LU2023250843.SGD","LU1023059063.AUD","MEDI","LU2324357040.USD","IE0004445239.USD","LU2360032135.SGD","LU1267930730.SGD","BK4551","LU2468319806.SGD","IE00B2B36J28.USD","IE00BSNM7G36.USD","PJP","LU1720051017.SGD","LLY","LU0456855351.SGD","LU0985320562.USD","LU1989772923.USD","LU1868837300.USD","LU0006306889.USD","LU0823416689.USD","LU1066051498.USD","LU0320765992.SGD","LU1057294990.SGD","LU2023251221.USD","LU1941712348.USD","LU2433249047.HKD","LU0640476718.USD","LU1430594728.SGD","LU1917777945.USD","SG9999014880.SGD","LU2023250504.SGD","LU1093756325.SGD","LU1712237335.SGD","BK4585","LU0306807586.USD","LU1064131342.USD","LU0820561818.USD","BMED","IE00B19Z3581.USD","LU0114720955.EUR","BK4139","LU1988902786.USD","SG9999001176.USD","LU2471134523.USD","LU0320765489.SGD","LU1941712264.USD","LU0980610538.SGD","SG9999002232.USD","IE00BJJMRY28.SGD","IE0009355771.USD","LU0203347892.USD","BK4501","IE00BKDWB100.SGD","LU0203201768.USD","PFE","LU0683600562.USD","LU2471134879.HKD","SGXZ81514606.USD","LU0432979614.USD","LU2462591350.SGD","LU1037948541.HKD","LU0106261372.USD","LU1934455863.HKD","IE00BFTCPJ56.SGD","SG9999015358.SGD","LU1691799644.USD","AGNG","LU1868836591.USD","LU1145028129.USD","IE00BK4W5M84.HKD","LU0689626769.HKD","SG9999014898.SGD","LU2552382058.USD","TMED","LU0122379950.USD","IE00BJJMRZ35.SGD","SG9999018857.SGD","LU0786609619.USD","LU2211815571.USD","IE00B1BXHZ80.USD","LU0965508806.USD","MRK","LU2089284900.SGD","IE000M9KFDE8.USD","LU1116320901.HKD","LU0385154629.USD","IE00BK4W5L77.USD","LU0225284248.USD","LU2491050154.USD","LU1571399168.USD","LU0170899867.USD","MRNX","LU1069347547.HKD","LU2236285917.USD","LU2750360997.AUD","SGXZ51526630.SGD","IE00B7KXQ091.USD","BK4581","BK4592","LU1868836757.USD","MHIP","LU0820562030.AUD","LU0320765059.SGD","SG9999011175.SGD","SG9999015952.SGD","LU1814569148.SGD","SG9999014906.USD","IE0004445015.USD","LU0672654240.SGD","LU1868837136.USD","IE00BLSP4452.SGD","LU0225771236.USD","LU0158827948.USD","SGXZ99366536.SGD","IE00BN29S564.USD","LU0158827781.USD","BK4548","LU0198837287.USD","LU2213496289.HKD","LU2237443978.SGD","LU2746668974.SGD","SGXZ31699556.SGD","LU0225283273.USD","LU0208291251.USD","LU0256863902.USD","CANC","BK4533","ELIL","LU0321505868.SGD","FTXH","LU1979441026.SGD","LU2237438978.USD","SG9999001440.SGD","LLII","SG9999015978.USD","LU1280957306.USD","LU2271345857.HKD","THNR","LU1623119135.USD","LU2756315664.SGD","LU1116320737.USD","LU0787776722.HKD","SG9999001176.SGD","LU2462157665.USD","OZEM","LU0417517546.SGD","BK4550","LU2237443895.HKD","LU2089984988.USD","LU0861579265.USD","IE00B4JS1V06.HKD","IE00BLSP4239.USD","LU0942090050.USD","LU1989771016.USD","LU0882574055.USD","LU1069344957.HKD","IE0002141913.USD","LU0345770993.USD","GB00BDT5M118.USD","BK4599","TRUH","LU1066053197.SGD","IE00BKPKM429.USD","LU0265550359.USD","LU2028103732.USD","CURE","LU2750360641.GBP","LU1894683348.USD","LU0345770308.USD","IE00B19Z3B42.SGD","BK4516","LU2461242641.AUD","LU1989772840.SGD","LU0210536198.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661264552","title":"Johnson & Johnson Says Multiple Myeloma Treatment Approved by European Commission","url":"https://stock-news.laohu8.com/highlight/detail?id=2661264552","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661264552?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:23","pubTimestamp":1787307791,"startTime":"0","endTime":"0","summary":"Johnson & Johnson's  Tecvayli plus daratumumab has been approved by the European Commission as a treatment for adults with relapsed or refractory multiple myeloma, the company said Friday.The approval was based on a 487-patient phase 3 study of the immunotherapy combination that showing statistically significant improvements in progression-free and overall survival versus standard of care treatments, the company saidThe two drugs complement each other with daratumumab modulating the immune system to enhance T-cell fitness and activation, amplifying teclistamab's  killing of myeloma cells, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2505996509.AUD","LU1221951046.USD","LU0426412945.USD","LU0787776722.HKD","IE00BGHQF631.EUR","RXL","LU1228905037.USD","IE0002270589.USD","MEDX","LU2112291526.USD","LU0689472784.USD","IXJ","LU0058720904.USD","LU0795875169.SGD","LU2456880835.USD","PJP","IE00BJT1NW94.SGD","VHT","LU1074936037.SGD","FHLC","IE0000B7K699.USD","LU2023250330.USD","LU0098860793.USD","JDOC","LU0795875086.SGD","JNJ","FTXH","BK4559","LU0994945656.USD","LU1043141123.HKD","LU0426417589.USD","IE00BJJMRZ35.SGD","BK4592","IE00B1BXHZ80.USD","BK4504","IE00B4R5TH58.HKD","TRUH","IHE","LU0203345920.USD","EPV","GDOC","IYH","XLV","BMED","LU0124676726.USD","LU2403377893.USD","LU0912757837.SGD","IE00B42XCP33.USD","IE0009355771.USD","IE000MB6IJN5.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151570295","title":"Guizhou Unveils 13 Typical Cases of Consumer Rights Violations in Market Regulation Crackdown","url":"https://stock-news.laohu8.com/highlight/detail?id=1151570295","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151570295?lang=en_us&edition=fundamental","pubTime":"2026-08-21 16:52","pubTimestamp":1787302339,"startTime":"0","endTime":"0","summary":"In recent years, market regulatory authorities in Guizhou Province have continuously carried out the \"Guardian of Consumption\" enforcement campaign, cracking down on illegal activities that have...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","BK1583","LNGR","AGNG","BK1574","09996","MDEV","MEDX","RSPH","IEIH","PTH","LGHT","HART","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250247","title":"Press Release: 3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250247","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250247?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:24","pubTimestamp":1787297040,"startTime":"0","endTime":"0","summary":"SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- 3S Bio (01530.HK) today announced its interim results for the first half of 2026. During the period, the Company recorded revenue of RMB 4.53 billion, represent","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","BK1161","NVIB","BK4022","IDNA","GDOC","BK1583","HK0000165453.HKD","HYLG","01530","BK4232","MEDX","R","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158851231","title":"Apichope's Subsidiary Gains Regulatory Nod for Novel Drug Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1158851231","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158851231?lang=en_us&edition=fundamental","pubTime":"2026-08-21 11:52","pubTimestamp":1787284333,"startTime":"0","endTime":"0","summary":"Apichope Pharmaceutical Group Co., Ltd. (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou Yipinhong Pharmaceutical Co., Ltd., has received approval from the National Medical Products...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","LNGR","MDTX","300723","IBBQ","BMED","MEDX","BK1574","IBBJ","BK0239","BK1161","PSYK","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165297527","title":"When This Sector Rallies, Tech Takes a Backseat","url":"https://stock-news.laohu8.com/highlight/detail?id=1165297527","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165297527?lang=en_us&edition=fundamental","pubTime":"2026-08-21 09:10","pubTimestamp":1787274639,"startTime":"0","endTime":"0","summary":"On August 19th, the U.S. Treasury Department unexpectedly decided to at least double its long-term bond repurchase program, directly pushing global yields lower. While many assumed tech stocks would...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GCmain","SGUmain","SGCmain","518880","06978","BK1574","159934","LNGR","IBBQ","GLD","NUGT","BK1161","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661258777","title":"Press Release: Sunshine Guojian Releases 2026 Interim Report:","url":"https://stock-news.laohu8.com/highlight/detail?id=2661258777","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661258777?lang=en_us&edition=fundamental","pubTime":"2026-08-21 08:00","pubTimestamp":1787270400,"startTime":"0","endTime":"0","summary":"Innovation-driven, Steady AdvancementSHANGHAI, Aug. 20, 2026 /PRNewswire/ -- Today, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (hereinafter referred to as \"Sunshine Guojian\", stock code: 688","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","GDOC","BK1583","01530","IDNA","R","BK4022","BK0239","688336","MEDX","HK0000165453.HKD","NVIB","BK1593","BK4232","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661123770","title":"Perrigo Co. PLC Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2661123770","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661123770?lang=en_us&edition=fundamental","pubTime":"2026-08-21 05:36","pubTimestamp":1787261760,"startTime":"0","endTime":"0","summary":"DJ Perrigo Co. PLC Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Perrigo Co. PLC  slid 1.86% to $13.70 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.87% to 7,641.16 and Dow Jones Industrial Average  falling 1.32% to 52,759.21.The stock's fall snapped a two-day winning streak.Perrigo Co. PLC closed 44.32% below its 52-week high of $24.61, which the company achieved on August 22nd.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.21% to $267.37, Procter & Gamble Co.  fell 0.98% to $142.97, and Abbott Laboratories  fell 0.25% to $114.14.Trading volume  remained 1.2 million below its 50-day average volume of 3.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRUO","LU0203345920.USD","SG9999015358.SGD","PJP","IE00B2B36J28.USD","IHI","BK4585","LU0211331839.USD","SG9999014559.SGD","JDOC","IHE","IYH","LU2471134796.USD","LU2756315318.SGD","BK4566","IE0034235303.USD","LU1914381329.SGD","LU1280957306.USD","LU0689472784.USD","IE000SO60NU8.SGD","RXL","TMED","LU1066051811.HKD","FTXH","VHT","LU1121112475.USD","SGXZ57979304.SGD","MEDX","PG","IE00B3PB1722.GBP","IXJ","FSTA","UGE","LU2023250330.USD","ABT","LU0868494617.USD","XLP","JNJ","SG9999014567.USD","GDOC","PRGO","LU0545562505.USD","BMED","LU0234570918.USD","LU0868494708.USD","IE0002270589.USD","LU0466842654.USD","TRUH","FHLC","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661301152","title":"Does J&J’s MONARCH QUEST 3 Approval and MedTech Momentum Change The Bull Case For Johnson & Johnson (JNJ)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661301152","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661301152?lang=en_us&edition=fundamental","pubTime":"2026-08-21 05:24","pubTimestamp":1787261077,"startTime":"0","endTime":"0","summary":"In recent days, Johnson & Johnson reported past quarterly operational sales growth led by its Innovative Medicine and MedTech businesses and raised its full-year outlook while securing U.S. 510(k) and FDA clearances for the MONARCH QUEST 3 AI-enabled bronchoscopy software update.\nTaken together, stronger operating performance and regulatory progress in robotic lung procedures underscore how Johnson & Johnson is leaning on innovation across medicines and devices to reinforce its diversified...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/139677-main-header/1756253951625","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/139677-main-header/1756253951625"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-jnj/johnson-johnson/news/does-jjs-monarch-quest-3-approval-and-medtech-momentum-chang","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-jnj/johnson-johnson/news/does-jjs-monarch-quest-3-approval-and-medtech-momentum-chang","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4550","XLV","LU0345769631.USD","LU1066053197.SGD","PJP","LU0345769128.USD","LU2896262040.SGD","IE000WAW04H5.SGD","LU0792757196.USD","JDOC","IE00B19Z3B42.SGD","LU0210528500.USD","LU2133065610.SGD","BMED","LU1244550494.USD","BK4504","LU0689626769.HKD","LU2471134796.USD","LU0098860793.USD","IE00BDGV0183.EUR","IYH","LU0114720955.EUR","LU0426417589.USD","TRUH","LU1778281490.HKD","FHLC","LU1061106388.HKD","LU1032955483.USD","LU0964807845.USD","IE0009355771.USD","LU0640476718.USD","LU2129689605.HKD","LU1929549753.HKD","SG9999001176.USD","LU0234570918.USD","IE00BN8TJ469.HKD","LU1674673691.USD","IE00BFTCPJ56.SGD","IE00BVYPNW00.USD","SG9999001176.SGD","GDOC","LU2129689514.USD","IE000F7OJYX1.SGD","JNJ","RXL","MEDX","FTXH","IHE","LU2129689431.USD","IE00BBT3K403.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661369852","title":"AbbVie Targets Next-Gen BOTOX Combo With New Glabellar Lines Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2661369852","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661369852?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:32","pubTimestamp":1787243542,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) is launching a Phase 1 study called “A Phase 1 Study to Evaluate ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-next-gen-botox-combo-with-new-glabellar-lines-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-next-gen-botox-combo-with-new-glabellar-lines-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PJP","LU1162221912.USD","LU0234570918.USD","IE000MB6IJN5.SGD","FTXH","IYH","LU0211327993.USD","LU1934455194.USD","ABBV","LU2112291526.USD","XLV","BK4534","IXJ","IE00BN8TJ469.HKD","IE00BBT3K403.USD","LU0057025933.USD","LU2347655073.USD","IE00BFTCPJ56.SGD","TRUH","BK4533","LU2237443978.SGD","LU1291159041.SGD","LU2087621335.USD","LU2089284900.SGD","IE00BVYPNV92.GBP","AGNG","SG9999001440.SGD","LU1023059063.AUD","LU2347655156.SGD","GLAM","LU1430594728.SGD","LU0417517546.SGD","LU0203347892.USD","PPH","LU0170899867.USD","LU1934455863.HKD","MEDX","FHLC","LU1244550221.USD","LU0965508806.USD","IE00B2B36J28.USD","VHT","LU0943347566.SGD","LU1074936037.SGD","JDOC","LU1923622614.USD","RXL","BK4581","IE0009355771.USD","IE00BDGV0183.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661236602","title":"Eli Lilly Advances Early-Stage Eloralintide Trial: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2661236602","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661236602?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:31","pubTimestamp":1787243499,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. The Phase 1 study “A Phase 1, Open-label Study to Evaluate the Ph...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eli-lilly-advances-early-stage-eloralintide-trial-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eli-lilly-advances-early-stage-eloralintide-trial-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2264538146.SGD","LU1989771016.USD","JDOC","LU2746668461.USD","GDOC","LU0096364046.USD","LLYZ","LLII","LU1232071149.USD","CURE","LU2168564222.USD","ELIL","LU2168564065.EUR","LU1629891620.HKD","GB00BDT5M118.USD","LU1548497426.USD","LU2237443465.HKD","IE00B775H168.HKD","FHLC","LU0289739699.SGD","LU1280957306.USD","LU1093756168.USD","LU0417517546.SGD","LU2746668974.SGD","LU0882574139.USD","LU2471134879.HKD","IE00BJJMRY28.SGD","IE00BK4W5M84.HKD","LU0094547139.USD","LU1712237335.SGD","LU0354030438.USD","MHIP","IE00BK4W5L77.USD","LU0058720904.USD","LU0823434583.USD","LU2750360641.GBP","LU1868837300.USD","ELIS","LU0820561909.HKD","LU0061475181.USD","ILDR","LU2089283258.USD","BK4533","LU0820561818.USD","LU0266013472.USD","LU1974910355.USD","LU2896262040.SGD","LU1691799644.USD","LU1720051017.SGD","LU0882574055.USD","WDNA","LU0889565916.HKD","IYH","LLYX","SG9999018857.SGD","LU0320765059.SGD","IE00BJJMRZ35.SGD","BK4516","LU2087625088.SGD","LU2462157665.USD","LU0345770993.USD","LU2089984988.USD","SG9999018865.SGD","LU1145028129.USD","LU0198837287.USD","LU0174119429.USD","LU0640476718.USD","IE00BKPKM429.USD","IE00BKDWB100.SGD","LU2236285917.USD","SG9999001176.USD","OZEM","CANC","LU1551013425.SGD","LU0432979614.USD","LU0820562030.AUD","LU2271345857.HKD","LU0079474960.USD","LU0786609619.USD","LU2602419157.SGD","IE00B2B36J28.USD","LU2361044949.HKD","SG9999015945.SGD","LU0256863902.USD","SGXZ51526630.SGD","LU2023250504.SGD","IE0004445239.USD","LLY","LU0158827948.USD","LU1064131342.USD","SG9999014880.SGD","LU0943347566.SGD","FTXH","LU2357305700.SGD","LU0203202063.USD","SG9999015986.USD","VHT","LU2361045086.USD","LU1551013342.USD","LU2168564149.EUR","PPH","LU2108987350.USD","SG9999014914.USD","IE00BJJMRX11.SGD","LU1868837136.USD","IE00B1BXHZ80.USD","LU0320765992.SGD","LU1623119135.USD","LU0689472784.USD","LU2756315318.SGD","LU0471298694.HKD","LU1868836757.USD","IE00BFSS8Q28.SGD","LU1868836591.USD","LU1804176565.USD","SGXZ81514606.USD","LU0234572021.USD","LU0006306889.USD","LU2168564495.EUR","LU0787776722.HKD","LU0210536198.USD","LU2112291526.USD","IXJ","LU2491049909.HKD","MEDI","XLV","LU2213496289.HKD","LU2237443622.USD","LU2552382215.SGD","LU1023059063.AUD","LU1366192091.USD","RXL","SGXZ57979304.SGD","SGXZ99366536.SGD","TRUH","LU0683600562.USD","BK4534","LU0203201768.USD","BK4599","LU0823416689.USD","LU2237443549.SGD","LU1093756325.SGD","AGNG","IE0001KFT4U8.USD","LU0385154629.USD","LU2237443382.USD","LU2471134952.CNY","LU2063271972.USD","LU2324357040.USD","LU2237438978.USD","HRTS","LU0353189763.USD","LU0256863811.USD","LU0471298777.SGD","LU2361044865.SGD","SG9999001176.SGD","IE0004445015.USD","TMED","IE0009355771.USD","LU2028103732.USD","LU2111349929.HKD","LU2265009873.SGD","LU0323591593.USD","LU0964807845.USD","LU1868836914.USD","LU2106854487.HKD","LU2461242641.AUD","LU2089284900.SGD","IE00B4R5TH58.HKD","SG9999015952.SGD","LU1988902786.USD","LU0672654240.SGD","BK4581","PJP","BK4588","LU2468319806.SGD","LU2552382058.USD","LU0316494557.USD","LU2491050071.SGD","SGXZ31699556.SGD","BK4585","LU0225283273.USD","LU1291159041.SGD","LU2750360997.AUD","LU1814569148.SGD","IE0005OL40V9.USD","LU1267930730.SGD","LU1061106388.HKD","IE00BWXC8680.SGD","LU0133085943.USD","LU0109391861.USD","LU0122379950.USD","LU1917777945.USD","LU2023251221.USD","LU2462591350.SGD","SG9999017495.SGD","MEDX","LU0823434740.USD","IE00BJT1NW94.SGD","LU0353189680.USD","IE00BFTCPJ56.SGD","LU2471134523.USD","LU2471134796.USD","SG9999014898.SGD","BK4007","IE00B1XK9C88.USD","LU2360106947.USD","SG9999015978.USD","LU0158827781.USD","IE00BFSS7M15.SGD","IE00BJLML261.HKD","LU2552382132.HKD","LU0466842654.USD","IE00BN29S564.USD","LU0345770308.USD","LU1983299246.USD","SG9999014906.USD","LU1057294990.SGD","LU0354030511.USD","LU1127390331.HKD","LU0708995401.HKD","LU0456855351.SGD","LU2756315664.SGD","LU1979441026.SGD","LU2237443978.SGD","LU2211815571.USD","THNR","LU2023250330.USD","LU1720051108.HKD","LU2456880835.USD","LU2491050154.USD","SG9999013999.USD","LU1035775433.USD","LU0238689110.USD","LU0106261372.USD","LU0109394709.USD","LU1323610961.USD","IE00B7KXQ091.USD","IHE","LU0114720955.EUR","LU0097036916.USD","IE0002141913.USD","IE00B4JS1V06.HKD","LU1069344957.HKD","LU2417539215.USD","LU2237443895.HKD","LU2168563687.JPY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661236971","title":"Eli Lilly’s Lebrikizumab Trial Completion Signals New Growth Path in Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2661236971","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661236971?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:30","pubTimestamp":1787243409,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Eli Lilly And Company (LLY) has completed a Phase 3 trial called ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eli-lillys-lebrikizumab-trial-completion-signals-new-growth-path-in-atopic-dermatitis?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eli-lillys-lebrikizumab-trial-completion-signals-new-growth-path-in-atopic-dermatitis?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0820562030.AUD","MHIP","LU0266013472.USD","LU2461242641.AUD","RXL","ELIL","SG9999015978.USD","LU2089284900.SGD","LU2602419157.SGD","PPH","SG9999015986.USD","LU1323610961.USD","IE00BKPKM429.USD","LU1232071149.USD","LU0061475181.USD","LU1804176565.USD","LU0256863902.USD","LU2023251221.USD","LU2089283258.USD","LLYX","LU2361044949.HKD","SGXZ31699556.SGD","IYH","AGNG","LU0466842654.USD","SGXZ57979304.SGD","IXJ","LU2471134879.HKD","SG9999013999.USD","LU1720051017.SGD","LU0158827781.USD","LU0234572021.USD","LU1691799644.USD","LU0882574139.USD","LU2361045086.USD","OZEM","LU0943347566.SGD","LLII","LU2063271972.USD","IE00BFSS7M15.SGD","LU0354030511.USD","LU2237443978.SGD","LU0097036916.USD","SG9999001176.SGD","LU1145028129.USD","LU2028103732.USD","LU0058720904.USD","LU1551013342.USD","LU0096364046.USD","LU2750360641.GBP","LU2361044865.SGD","LU0238689110.USD","SGXZ51526630.SGD","LLYZ","LU0787776722.HKD","LU2237443549.SGD","LU0158827948.USD","SG9999014880.SGD","LU2746668974.SGD","MEDI","LU0006306889.USD","VHT","IE00B1XK9C88.USD","SG9999014906.USD","BK4581","LU0820561818.USD","LU2111349929.HKD","LU2360106947.USD","LU0456855351.SGD","LU2237443895.HKD","LLY","IE0002141913.USD","IE00BWXC8680.SGD","LU0786609619.USD","LU0109391861.USD","IE00B2B36J28.USD","LU1267930730.SGD","LU0672654240.SGD","LU1093756325.SGD","LU0708995401.HKD","LU2265009873.SGD","LU0345770308.USD","IE00B7KXQ091.USD","LU0353189680.USD","LU0889565916.HKD","LU0210536198.USD","SGXZ81514606.USD","LU0289739699.SGD","LU1974910355.USD","BK4599","LU2456880835.USD","TRUH","LU1366192091.USD","JDOC","LU2468319806.SGD","LU2896262040.SGD","LU0316494557.USD","IE0004445015.USD","LU0823434583.USD","LU1712237335.SGD","LU2087625088.SGD","LU2023250504.SGD","LU0683600562.USD","LU2264538146.SGD","LU0432979614.USD","GDOC","LU0320765059.SGD","LU0353189763.USD","LU1814569148.SGD","LU0225283273.USD","IE00BK4W5L77.USD","BK4534","SGXZ99366536.SGD","SG9999014898.SGD","LU2552382058.USD","IE00BJT1NW94.SGD","LU2471134796.USD","LU0882574055.USD","LU2750360997.AUD","THNR","LU2089984988.USD","IE0004445239.USD","IE00B775H168.HKD","IE00BFTCPJ56.SGD","IE00BJJMRY28.SGD","BK4585","LU1989771016.USD","LU2168564149.EUR","SG9999001176.USD","LU1979441026.SGD","CURE","LU1868837136.USD","LU0471298777.SGD","LU0114720955.EUR","LU2023250330.USD","LU2112291526.USD","LU2357305700.SGD","LU0820561909.HKD","LU1868836591.USD","LU2417539215.USD","LU1720051108.HKD","IHE","LU1127390331.HKD","SG9999017495.SGD","LU2168564495.EUR","LU1868837300.USD","LU1035775433.USD","LU2491049909.HKD","LU2491050154.USD","LU1057294990.SGD","LU0417517546.SGD","MEDX","LU2168564222.USD","LU0385154629.USD","LU1093756168.USD","LU2106854487.HKD","LU2271345857.HKD","LU1291159041.SGD","IE00BJJMRX11.SGD","LU1023059063.AUD","LU2237443622.USD","LU2237443465.HKD","BK4533","LU2324357040.USD","LU0823434740.USD","SG9999015945.SGD","BK4588","LU0106261372.USD","FTXH","LU0256863811.USD","LU1917777945.USD","LU2491050071.SGD","CANC","LU0122379950.USD","LU0471298694.HKD","LU0320765992.SGD","LU0689472784.USD","LU2471134523.USD","LU1061106388.HKD","IE0005OL40V9.USD","LU0640476718.USD","FHLC","BK4007","IE00BN29S564.USD","LU1064131342.USD","IE00B4R5TH58.HKD","LU2237438978.USD","IE00BJJMRZ35.SGD","LU0133085943.USD","LU0203201768.USD","LU0823416689.USD","LU2756315318.SGD","SG9999018857.SGD","LU0323591593.USD","TMED","XLV","LU0198837287.USD","LU1551013425.SGD","LU0964807845.USD","LU2552382215.SGD","IE00B4JS1V06.HKD","LU2211815571.USD","SG9999018865.SGD","LU2746668461.USD","LU0174119429.USD","LU1988902786.USD","LU0079474960.USD","LU1629891620.HKD","LU0094547139.USD","LU2168563687.JPY","LU2471134952.CNY","PJP","LU1868836914.USD","LU2236285917.USD","LU2756315664.SGD","LU2108987350.USD","LU0109394709.USD","LU1983299246.USD","LU0345770993.USD","IE00BK4W5M84.HKD","LU1069344957.HKD","LU1623119135.USD","LU2168564065.EUR","LU2237443382.USD","LU1548497426.USD","LU2462591350.SGD","ILDR","LU1868836757.USD","LU0354030438.USD","SG9999014914.USD","IE00BJLML261.HKD","BK4516","LU2462157665.USD","SG9999015952.SGD","GB00BDT5M118.USD","IE0009355771.USD","ELIS","IE00BKDWB100.SGD","LU1280957306.USD","IE00B1BXHZ80.USD","WDNA","LU2213496289.HKD","LU0203202063.USD","IE0001KFT4U8.USD","IE00BFSS8Q28.SGD","LU2552382132.HKD","HRTS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":12,"totalSize":242,"code":"91000000","status":"200"}]}}